Becker's Healthcare August 20, 2024
Many cardiac drugs have notoriously low adherence rates, but GLP-1s may be overcoming that problem, according to Northwell Health cardiologist, Jeffrey Wessler, MD.
“It is almost impossible now to manage patients and not have GLP-1s be part of that conversation,” Dr. Wessler told Becker’s. “In my view, and I think where the evidence is bringing us, is that what started as a medication for diabetics and weight loss is quickly becoming probably one of the best cardiac medications that exists. That’s for a fairly simple reason, which is that it may be the first medication that patients actually want to take because it has this amazing side effect of losing weight.”
Nonadherence to medications has been documented to happen...
Today's Sponsors
Today's Sponsor